Mary E. Rinella, MD
Dr. Rinella is currently Professor of Medicine in the Gastroenterology, Hepatology and Nutrition section at the University of Chicago since January 2021. She is the director of the Metabolic and Fatty Liver Program as well as Director of Clinical trials for the section.
She has held several leadership roles, including on the Governing Board of the American Association for the Study of Liver Disease (AASLD) and chaired numerous upper level national committees. She was the chair of the 2023 AASLD Clinical Practice Guidance on the diagnosis and management of NAFLD, now MASLD. She recently led a multi-society global effort to revise the nomenclature of NAFLD and serves as a Chair of the AASLD Steatotic Liver Disease (SLD) task force, charged with increasing disease awareness, disseminating best practice, developing a national strategy and fortifying global collaborations to improve care and outcomes of patients with SLD.